DEBRA PANKE: Open Payments
NPI 1548393531 · MANSFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 39 payments from 13 companies in 2025. Trend: 2023 $6,858 · 2024 $858 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 10 | $191 |
| Alkermes, Inc. | 6 | $150 |
| E.R. Squibb & Sons, L.L.C. | 4 | $141 |
| Corium, LLC | 5 | $105 |
| Lundbeck LLC | 4 | $67 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
Products named: Qelbree, COBENFY, Azstarys, LYBALVI, REXULTI, ARISTADA, Auvelity, FANAPT.
Industry payments across OH — which companies pay providers there.
